KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Work In Process (2016 - 2019)

NovoCure's Work In Process history spans 6 years, with the latest figure at $9.1 million for Q2 2019.

  • On a quarterly basis, Work In Process rose 73.08% to $9.1 million in Q2 2019 year-over-year; TTM through Jun 2019 was $9.1 million, a 73.08% increase, with the full-year FY2018 number at $8.7 million, up 2.75% from a year prior.
  • Work In Process hit $9.1 million in Q2 2019 for NovoCure, up from $8.2 million in the prior quarter.
  • Over the last five years, Work In Process for NVCR hit a ceiling of $11.0 million in Q2 2017 and a floor of $3.2 million in Q3 2015.
  • Historically, Work In Process has averaged $7.5 million across 5 years, with a median of $8.2 million in 2016.
  • Biggest five-year swings in Work In Process: skyrocketed 260.78% in 2015 and later crashed 51.99% in 2018.
  • Tracing NVCR's Work In Process over 5 years: stood at $4.6 million in 2015, then surged by 79.56% to $8.3 million in 2016, then increased by 1.72% to $8.4 million in 2017, then grew by 2.75% to $8.7 million in 2018, then rose by 5.18% to $9.1 million in 2019.
  • Business Quant data shows Work In Process for NVCR at $9.1 million in Q2 2019, $8.2 million in Q1 2019, and $8.7 million in Q4 2018.